21 CFR Part 11 is a regulation that defines the criteria for ensuring trustworthy and reliable electronic records and electronic signatures in computerized systems of FDA regulated pharmaceutical industries. It is only meaningful for instruments connected to a computer and using software. Several companies from the pharmaceutical industry have recently asked for 21 CFR Part 11 certification for instruments not connected to a PC, just using the instruments' firmware. Please watch why experts state, that electronic records on instruments bare significant regulatory risks and concepts offered in the market that look like a feasible workaround are rather dangerous because they may result in a data loss and even worse scenarios.
The webinar includes an interview with Bob McDowall, a renowned expert for computer validation in regulated environments. Find suggestions for a more secure and automatic dataflow solution with LabX according to 21 CFR Part 11 or "Annex 11".
Thu Mar 21 2019 17:00 +0100 [ English ]
Thu Jul 25 2019 09:00 +0200 [ English ]
Thu Jul 25 2019 17:00 +0200 [ English ]
Thu Nov 21 2019 09:00 +0100 [ English ]
Thu Nov 21 2019 17:00 +0100 [ English ]
- The concept: Why would this be a good idea?
- Background information
- USP <1058>
- Paper records
- ALCOA and meta data
- FDA warning letters
- Conclusion: Why you should not do this. Expert opinion!
- Automatic data flow: how it should be
- Why LabX is a lean solution.